Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
acyline (2 trials)
zoledronic acid (zometa) (1 trial)
Prostatic Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (2 total)